Literature DB >> 9430471

Dosimetric framework for therapeutic alpha-particle emitters.

J C Roeske1, T G Stinchcomb.   

Abstract

UNLABELLED: Alpha-particle emitters are currently being considered for the treatment of metastatic disease. However, the dosimetry of alpha-particle emitters is a challenge because the dimensions of subcellular targets (e.g., the cell nucleus) are of the same order of magnitude as the range of the particle. Hence, a single dose value is often not representative of the dose delivered to a cell population. Here, we propose a dosimetry system that combines the calculational ease of the Medical Internal Radiation Dosimetry (MIRD) system with the additional information provided by microdosimetry.
METHODS: Beginning with the microdosimetric, single-event specific-energy spectrum, we derived expressions for the first and second moments. Using the MIRD S-factor along with these moments, we determined not only the mean absorbed dose but also the s.d. and the fraction of cells receiving zero (or any number of) hits.
RESULTS: Using the formalism developed here, we have generated tables for a simple example to demonstrate the use of this method.
CONCLUSION: We have developed a formalism for the rapid determination of not only the mean absorbed dose but also the s.d. and fraction of cells receiving zero hits. These parameters are potentially useful in analyzing the biological outcome for cells exposed to alpha-particle irradiation.

Mesh:

Year:  1997        PMID: 9430471

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  8 in total

Review 1.  Challenges and progress in predicting biological responses to incorporated radioactivity.

Authors:  R W Howell; P V S V Neti; M Pinto; B I Gerashchenko; V R Narra; E I Azzam
Journal:  Radiat Prot Dosimetry       Date:  2007-02-06       Impact factor: 0.972

2.  Small-scale dosimetry for alpha particle 241Am source cell irradiation and estimation of γ-H2AX foci distribution in prostate cancer cell line PC3.

Authors:  Emma Mellhammar; Magnus Dahlbom; Oskar Vilhelmsson-Timmermand; Sven-Erik Strand
Journal:  EJNMMI Phys       Date:  2022-07-19

3.  MIRD Pamphlet No. 22 (abridged): radiobiology and dosimetry of alpha-particle emitters for targeted radionuclide therapy.

Authors:  George Sgouros; John C Roeske; Michael R McDevitt; Stig Palm; Barry J Allen; Darrell R Fisher; A Bertrand Brill; Hong Song; Roger W Howell; Gamal Akabani; Wesley E Bolch; A Bertrand Brill; Darrell R Fisher; Roger W Howell; Ruby F Meredith; George Sgouros; Barry W Wessels; Pat B Zanzonico
Journal:  J Nucl Med       Date:  2010-01-15       Impact factor: 10.057

4.  Cellular and Genetic Determinants of the Sensitivity of Cancer to α-Particle Irradiation.

Authors:  Brian D Yard; Priyanka Gopal; Kristina Bannik; Gerhard Siemeister; Urs B Hagemann; Mohamed E Abazeed
Journal:  Cancer Res       Date:  2019-08-06       Impact factor: 12.701

5.  In Vitro comparison of 213Bi- and 177Lu-radiation for peptide receptor radionuclide therapy.

Authors:  Ho Sze Chan; Erik de Blois; Alfred Morgenstern; Frank Bruchertseifer; Marion de Jong; Wouter Breeman; Mark Konijnenberg
Journal:  PLoS One       Date:  2017-07-21       Impact factor: 3.240

6.  Fluorescent nuclear track detectors for alpha radiation microdosimetry.

Authors:  J J M Kouwenberg; H T Wolterbeek; A G Denkova; A J J Bos
Journal:  Radiat Oncol       Date:  2018-06-07       Impact factor: 3.481

7.  Technical Note: The development of a multi-physics simulation tool to estimate the background dose by systemic targeted alpha therapy.

Authors:  T Xu; T Liu; G Li; C Dugal; N A Aydemir; Y Liu; J C Roeske
Journal:  Med Phys       Date:  2020-03-31       Impact factor: 4.071

8.  Microdosimetry for targeted alpha therapy of cancer.

Authors:  Chen-Yu Huang; Susanna Guatelli; Bradley M Oborn; Barry J Allen
Journal:  Comput Math Methods Med       Date:  2012-09-04       Impact factor: 2.238

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.